v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenue        
Collaboration revenue $ 215,385 $ 33,257 $ 215,385 $ 33,257
Total revenue 215,385 33,257 215,385 33,257
Cost of revenue        
Cost of collaboration revenue 108,486 26,735 108,486 26,735
Total cost of revenue 108,486 26,735 108,486 26,735
Gross profit 106,899 6,522 106,899 6,522
Operating expenses        
Research and development 339,456 480,297 774,275 1,056,557
General and administrative 1,186,504 995,898 2,366,312 2,476,258
Total operating expenses 1,525,960 1,476,195 3,140,587 3,532,815
Loss from operations (1,419,061) (1,469,673) (3,033,688) (3,526,293)
Other income (expense), net        
Interest expense (2,373) (2,449) (3,355) (3,464)
Interest income 49,904 23,393 66,293 63,475
Other income 0 0 6,059 0
Total other income (expense), net 47,531 20,944 68,997 60,011
Net loss $ (1,371,530) $ (1,448,729) $ (2,964,691) $ (3,466,282)
Net loss per common share attributable to common stockholders - basic (in dollars per share) $ (0.07) $ (0.15) $ (0.19) $ (0.36)
Net loss per common share attributable to common stockholders - diluted (in dollars per share) $ (0.07) $ (0.15) $ (0.19) $ (0.36)
Weighted average number of shares outstanding - basic (in shares) 18,807,779 9,706,356 15,894,441 9,698,130
Weighted average number of shares outstanding - diluted (in shares) 18,807,779 9,706,356 15,894,441 9,698,130